substance-use-disorders

Documents about substance-use-disorders

• Woebot for Substance Use Disorders#841760ClinicalTrials.gov
• Brief Intervention in Primary Care for Problem Drug Use and Abuse#810220ClinicalTrials.gov
• Trauma-Focused Intervention With Women Experiencing Homelessness#980792ClinicalTrials.gov
• Cognitive Training in Inpatient Treatment for Substance Use Disorders#807548ClinicalTrials.gov
• Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation#834831ClinicalTrials.gov
• Behavioral Treatment of Adolescent Substance Use#995204ClinicalTrials.gov
• Mindfulness and Meditation-Based Relapse Prevention for Substance Use Disorders#915796ClinicalTrials.gov
• Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)#914813ClinicalTrials.gov
• Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care#896830ClinicalTrials.gov
• What is the multidisciplinary approach to substance use disorders?#31561DataCite
• What is the multidisciplinary approach to substance use disorders?#31562DataCite
• Massed Prolonged Exposure for PTSD in Substance Use Treatment#850738ClinicalTrials.gov
• Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity#829211ClinicalTrials.gov
• Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders#893790ClinicalTrials.gov
• Substance Use and Eating Disorders : Food Craving and Addiction Transfer#967940ClinicalTrials.gov
• Adaptive Treatment for Adolescent Cannabis Use Disorders#844384ClinicalTrials.gov
• Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone#887551ClinicalTrials.gov
• Non-Invasive Brain Stimulation and Substance Use#1007659ClinicalTrials.gov
• Multifamily Group Psychoeducation for SUD's in Turkey#917930ClinicalTrials.gov
• Strategies to Enhance Recruitment and Retention of Black Individuals Into Clinical Trials for Substance Use Disorders#812712ClinicalTrials.gov
• Evaluation of the ADD'Pro Vocational Reintegration Program (ADD-PRO-EVAL)#831586ClinicalTrials.gov
• Incentives to Decrease Opioid Use - Pilot#850407ClinicalTrials.gov
• Psychotherapy for Psychosis, Adverse Events, and Substance Misuse#867488ClinicalTrials.gov
• Validation of the Behavioral Activation for Depression Scale in Individuals With Substance Use Disorders#914437ClinicalTrials.gov
• Cognitive Stimulation#877008ClinicalTrials.gov
• Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics#968403ClinicalTrials.gov
• Data-driven Identification for Substance Misuse#856156ClinicalTrials.gov
• Preventing OUD in Justice-Involved Youth#893907ClinicalTrials.gov
• Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates#846668ClinicalTrials.gov
• Delivering Contingency Management in Outpatient Addiction Treatment#902148ClinicalTrials.gov
• Enhancing Adolescent Substance Abuse Treatment#867785ClinicalTrials.gov
• Enhancing Prospective Thinking in Early Recovery#1009499ClinicalTrials.gov
• Transtheoretical components of evidence-based psychological interventions for substance use disorders#143927OSF
• F-CaST for Individuals With Substance Use Disorder#810899ClinicalTrials.gov
• Twelve Step Based Self-help Groups for Substance Related Disorders#847846ClinicalTrials.gov
• Substance Misuse To Psychosis for Ketamine (SToP-K)#889188ClinicalTrials.gov
• Screening and Brief Advice to Reduce Teen Substance Use#859791ClinicalTrials.gov
• Prescription Trends for Bipolar Disorder With and Without Comorbid Substance Use and Anxiety Disorders: A Global Bipolar Cohort Collaborative Study#476058HAL (France)
• Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology#910042ClinicalTrials.gov
• Enhancing Prospective Thinking in Early Recovery (PARK)#858889ClinicalTrials.gov
• Substance Use Prevention for Youth With Parents in Recovery#824935ClinicalTrials.gov
• Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders#878643ClinicalTrials.gov
• Recovery Opportunities Through Ongoing Treatment Sustainment#846462ClinicalTrials.gov
• Indigenous Recovery Planning for American Indians#913628ClinicalTrials.gov
• Substance Use Craving Following Detoxification During Community-Based Residential Treatment for Substance Use Disorders: The Influences of Social Anxiety and Self-Esteem#625666LSU Digital Commons
• Entolimod, an Adjuvant for Vaccine Augmentation#623555ClinicalTrials.gov
• Distress Tolerance for Benzodiazepine Discontinuation#868378ClinicalTrials.gov
• Written Exposure Therapy for Veterans With SUD and PTSD#851867ClinicalTrials.gov
• Effectiveness of an Evidence-based Stepped Care System for Alcohol and Other Drug Use Problems Among Congolese Refugees in Zambia#864774ClinicalTrials.gov
• Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)#888644ClinicalTrials.gov